JP Patent

JP6203816B2 — 回腸及び虫垂に対して活性の胃腸部位特異的経口ワクチン接種製剤

Assigned to セラバイオーム，エルエルシー · Expires 2017-09-27 · 9y expired

What this patent protects

Patent listed against risedronate-sodium.

Drugs covered by this patent

Patent Metadata

Patent number
JP6203816B2
Jurisdiction
JP
Classification
—
Expires
2017-09-27
Drug substance claim
No
Drug product claim
No
Assignee
セラバイオーム，エルエルシー
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.